東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Fatigue and sleep disturbances in ad...

The University of Utah.

FindBook

Google Book

Amazon

博客來

Fatigue and sleep disturbances in adolescents receiving chemotherapy.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Fatigue and sleep disturbances in adolescents receiving chemotherapy./
作者:	Erickson, Jeanne M.
面頁冊數:	239 p.
附註:	Source: Dissertation Abstracts International, Volume: 69-08, Section: B, page: 4665.
Contained By:	Dissertation Abstracts International69-08B.
標題:	Health Sciences, Nursing. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3329058
ISBN:	9780549821083

Fatigue and sleep disturbances in adolescents receiving chemotherapy.
Erickson, Jeanne M.

Fatigue and sleep disturbances in adolescents receiving chemotherapy. - 239 p.

Source: Dissertation Abstracts International, Volume: 69-08, Section: B, page: 4665.

Thesis (Ph.D.)--The University of Utah, 2008.

Fatigue is a prevalent and distressing symptom for adolescents during cancer treatment. Adolescents complain that fatigue is affected by sleep-wake disturbances, but little is known about the association between these symptoms and how they vary over time in adolescent patients. Aims of this study, based on a developmental science framework, were to describe patterns of fatigue and sleep-wake disturbances of adolescents during one month of chemotherapy. Associations between fatigue, sleep-wake disturbances, and quality of life were also explored. The study used mixed methods of self-report to collect data from 20 adolescents with a variety of cancer diagnoses. The adolescents described their daily fatigue using rating scales and qualitative diaries. Multidimensional fatigue and quality of life were measured weekly with modules from the PedsQL(TM) Measurement Model, and sleep-wake disturbances were measured with the General Sleep Disturbance Scale. Data analysis was conducted using visual graphic analysis techniques and nonparametric statistics. For adolescents who received chemotherapy every 3 to 4 weeks, the most common fatigue trajectory was an increase in fatigue severity 1 to 3 days after chemotherapy, followed by a declining 'roller-coaster' trend that continued until their next treatment. Adolescents who received weekly chemotherapy showed more frequent peaks and troughs in fatigue severity that did not diminish across one month. These adolescents complained of frequent daytime sleepiness and poor sleep quality. Increased symptom severity and decreased quality of life occurred during the week after treatment. Fatigue was associated with sleep-wake disturbances (r = 0.49--0.70, p < 0.05) across the weeks of the study, and both symptoms were associated with generic (r = 0.49--0.92, p < 0.05) and cancer-related (r = 0.51--0.85, p < 0.05) quality of life. Fatigue prevented some adolescents from participating in physical and social activities, but many remained active in school and extracurricular activities. Oncology clinicians should screen adolescent patients for fatigue and sleep-wake disturbances, especially during the week after treatment, and implement symptom management interventions to promote optimal activity-sleep cycles. Continued research needs to refine measurement techniques and test management strategies for these common symptoms so that adolescents remain involved in activities critical to their developmental stage during cancer treatment.

ISBN: 9780549821083Subjects--Topical Terms:

1017798
Health Sciences, Nursing.

Fatigue and sleep disturbances in adolescents receiving chemotherapy.
LDR:03298nam 2200253 a 45 001 856970
005 20100709
008 100709s2008 ||||||||||||||||| ||eng d
020 $a 9780549821083
035 $a (UMI)AAI3329058
035 $a AAI3329058
040 $a UMI $c UMI
100 1 $a Erickson, Jeanne M. $3 1023869
245 1 0 $a Fatigue and sleep disturbances in adolescents receiving chemotherapy.
300 $a 239 p.
500 $a Source: Dissertation Abstracts International, Volume: 69-08, Section: B, page: 4665.
502 $a Thesis (Ph.D.)--The University of Utah, 2008.
520 $a Fatigue is a prevalent and distressing symptom for adolescents during cancer treatment. Adolescents complain that fatigue is affected by sleep-wake disturbances, but little is known about the association between these symptoms and how they vary over time in adolescent patients. Aims of this study, based on a developmental science framework, were to describe patterns of fatigue and sleep-wake disturbances of adolescents during one month of chemotherapy. Associations between fatigue, sleep-wake disturbances, and quality of life were also explored. The study used mixed methods of self-report to collect data from 20 adolescents with a variety of cancer diagnoses. The adolescents described their daily fatigue using rating scales and qualitative diaries. Multidimensional fatigue and quality of life were measured weekly with modules from the PedsQL(TM) Measurement Model, and sleep-wake disturbances were measured with the General Sleep Disturbance Scale. Data analysis was conducted using visual graphic analysis techniques and nonparametric statistics. For adolescents who received chemotherapy every 3 to 4 weeks, the most common fatigue trajectory was an increase in fatigue severity 1 to 3 days after chemotherapy, followed by a declining 'roller-coaster' trend that continued until their next treatment. Adolescents who received weekly chemotherapy showed more frequent peaks and troughs in fatigue severity that did not diminish across one month. These adolescents complained of frequent daytime sleepiness and poor sleep quality. Increased symptom severity and decreased quality of life occurred during the week after treatment. Fatigue was associated with sleep-wake disturbances (r = 0.49--0.70, p < 0.05) across the weeks of the study, and both symptoms were associated with generic (r = 0.49--0.92, p < 0.05) and cancer-related (r = 0.51--0.85, p < 0.05) quality of life. Fatigue prevented some adolescents from participating in physical and social activities, but many remained active in school and extracurricular activities. Oncology clinicians should screen adolescent patients for fatigue and sleep-wake disturbances, especially during the week after treatment, and implement symptom management interventions to promote optimal activity-sleep cycles. Continued research needs to refine measurement techniques and test management strategies for these common symptoms so that adolescents remain involved in activities critical to their developmental stage during cancer treatment.
590 $a School code: 0240.
650 4 $a Health Sciences, Nursing. $3 1017798
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0569
690 $a 0992
710 2 $a The University of Utah. $3 1017410
773 0 $t Dissertation Abstracts International $g 69-08B.
790 $a 0240
791 $a Ph.D.
792 $a 2008
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3329058